Morgan Stanley’s Inhibikase Therapeutics IKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$276K	Buy	164,259 +84,577	+106%	+$150K	﹤0.01%	5732
2025 Q4	$163K	Buy	79,682 +23,663	+42%	+$37.7K	﹤0.01%	6007
2025 Q3	$90.8K	Sell	56,019 -43,659	-44%	-$75.6K	﹤0.01%	6193
2025 Q2	$194K	Buy	99,678 +78,032	+360%	+$153K	﹤0.01%	5862
2025 Q1	$47.4K	Buy	21,646 +14,350	+197%	+$36K	﹤0.01%	6286
2024 Q4	$23.7K	Buy	7,296 +5,629	+338%	+$14K	﹤0.01%	6516
2024 Q3	$2.17K	Hold	1,667	–	–	﹤0.01%	7117
2024 Q2	$2.02K	Hold	1,667	–	–	﹤0.01%	7066
2024 Q1	$3.6K	Sell	1,667 -1,667	-50%	-$3.68K	﹤0.01%	6962
2023 Q4	$4.23K	Buy	3,334 +1,667	+100%	+$1.73K	﹤0.01%	7031
2023 Q3	$2.32K	Hold	1,667	–	–	﹤0.01%	7100
2023 Q2	$6.02K	Hold	1,667	–	–	﹤0.01%	6942
2023 Q1	$6.58K	Hold	1,667	–	–	﹤0.01%	6997
2022 Q4	$5K	Hold	1,667	–	–	﹤0.01%	7145
2022 Q3	$9K	Hold	1,667	–	–	﹤0.01%	7107
2022 Q2	$7K	Buy	+1,667	New	+$9.83K	﹤0.01%	7320
2022 Q1	–	Hold	0	–	–	–	8031
2021 Q4	–	Hold	0	–	–	–	8028